succinylacetone has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, C | 1 |
| Cicalini, I | 1 |
| Cufaro, MC | 1 |
| Agnifili, L | 1 |
| Mastropasqua, L | 1 |
| Lanuti, P | 1 |
| Marchisio, M | 1 |
| De Laurenzi, V | 1 |
| Del Boccio, P | 1 |
| Pieragostino, D | 1 |
1 other study available for succinylacetone and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients.
Topics: Aged; Biomarkers; Carnitine; Female; Glaucoma, Open-Angle; Heptanoates; Humans; Lysophospholipids; M | 2019 |